Asset managers ask pharmaceutical companies to stop competing in the hunt for a corona vaccine
Important shareholders in the global pharmaceutical industry, including asset and pension managers, are asking pharmaceutical companies to work together to develop a coronavirus vaccine or treatment.
The world's largest investors and asset managers are encouraging pharmaceutical companies to work together to develop a corona vaccine to put a stop to the global economic crisis caused by the pandemic, the Financial Times reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Catella warns of significant corona effect
For subscribers
